The intensive growth of the cannabis recreational market alone was estimated in a 2016 Deloitte survey to reach $5B per year with a potential economic impact of $23B. Dedicated scientific research capacity is needed to fill in gaps to support this growth for recreational and medicinal use. Existing knowledge on cannabis production is often based on anecdotal experiences and poorly designed experiments, illustrating a need for rigorous defensible research design and implementation.
To create the Guelph Centre for Cannabis Research (GCCR), a research facility that will focus on a range of areas including genetics, production, medicinal compound analysis, human and animal health benefits and much more, the University of Guelph is looking to raise $20M.
The GCCR will provide opportunities for interested researchers, technology suppliers and licensed producers to perform high-value collaborative and multidisciplinary research at a centralized facility. Projects will include breeding and phenotype testing of strains targeted to certain animal or human disorders, extraction and analysis of medicinal compounds, development of environment control recipes for standardized production, pharmacological studies and coordination with human and animal clinical trials plus many more.
The knowledge and technologies generated from the centre will be essential for Canada’s cannabis industry and useful to other fields including indoor farming and advanced horticultural production and technologies.
To produce cannabis for medical and recreational purposes, quality and standardization are key. Canada will be one of a handful of countries globally to have legalized cannabis production and use, creating an opportunity for industry leadership. U of G is the first university in North America to have conducted legitimized research on cannabis production in controlled environments and published the results in the scientific literature, positioning us well for the GCCR.
Investment in this initiative will establish the GCCR by: